CEO McKenzie stated that CSL's differentiation strategy and focus on innovation will support the company's position. Analysts ...
PolyNovo (ASX:PNV) has announced that its chief executive officer, Swami Raote, will officially leave the company in June but ...
Medical devices manufacturer PolyNovo has announced that its chief executive Swami Raote will step down from his role ...
In a conference call with investment analysts last year, CSL CEO Paul McKenzie said sales of Hemgenix have progressed slower than expected. "We had 12 [patients on the therapy] in 2024," McKenzie ...
Therapeutics announced it has entered into a license and distribution agreement with CSL Seqirus for the exclusive rights to ...
Esperion Therapeutics (NASDAQ: ESPR) today announced it has entered into a license and distribution agreement with CSL Seqirus (ASX:CSL) for the exclusive rights to commercialize NEXLETOL ® (bempedoic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results